Nutex Health, Inc.
NASDAQ:NUTXMedical - Healthcare Information Services
+$2.84 today
- Market cap
- $1.19B
- Beta
- 2.06
- P/E (TTM)
- 10.4
- EPS (TTM)
- $14.38
Volume 0.16M
Average 0.17M
NUTX Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Nutex Health, Inc.NASDAQ: NUTX
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses dips below year-ago levels
Q1 FY2026 operating expenses of $10.47M fell 77.3% year over year, behind the +37.2% change in trailing-twelve-month operating expenses. Sequentially, it fell 31.2% from the prior quarter. Over 3 fiscal years it compounded at -26.3% a year.
Context
- Operating expenses amounted to 19.3% of revenue in FY2025, up 5.6 pp from a year earlier.
- Operating expenses increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -77.3% toward the trailing-twelve-month pace of +37.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 168.66M USD
- Year-over-year change
- +156.9%
- 4-year CAGR
- +108.0%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 168.66M | +156.9% |
| FY2024 | 2024-12-31 | 65.64M | -1.4% |
| FY2023 | 2023-12-31 | 66.55M | -84.2% |
| FY2022 | 2022-12-31 | 422.02M | +4580.8% |
| FY2021 | 2021-12-31 | 9.02M | — |
Operating Expenses vs competitors
How NUTX compares with its peers on the latest reported figures
- NUTX's LTM Mar 2026 operating expenses of $141.44M is the lowest of the 11 companies compared; the peer median is $967.05M.
- Its year-over-year change of +37.2% is the 2nd highest of 11, against a peer median of -1.0%.
- Operating expenses amounts to 16.1% of revenue for NUTX, versus a peer median of 14.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $20.08B | +328.5% | +39.1% | 93.5% | |
| LTM Jun 2026 | $14.37B | +10.3% | +7.9% | 79.3% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $2.62B | -38.8% | +13.9% | 40.7% |
| LTM Jun 2026 | $2.2B | -75.8% | +44.0% | 10.1% | |
| LTM Jun 2026 | $1.61B | +11.9% | +10.4% | 25.9% | |
| LTM Sep 2026 | $328.8M | -13.5% | +17.8% | 9.8% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | $303.23M | +12.7% | +23.0% | 13.0% |
| LTM Mar 2026 | $242M | +24.7% | +31.7% | 6.9% | |
| LTM Mar 2026 | $233.46M | -18.8% | +2.4% | 4.0% | |
| LTM Mar 2026 | $159.23M | -12.2% | +63.8% | 16.8% | |
| LTM Mar 2026 | $141.44M | +37.2% | -26.3% | 16.1% | |
| Peer median (excluding NUTX) | $967.05M | -1.0% | +20.4% | 14.9% | |
Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 331.53M | 219.29M | 247.65M | 479.95M | 875.26M |
| Cost of Revenue | 152.25M | 203.87M | 212.87M | 283.69M | 430.98M |
| Gross Profit | 179.28M | 15.42M | 34.77M | 196.26M | 444.28M |
| Gross Margin | 54.1% | 7.0% | 14.0% | 40.9% | 50.8% |
| Research & Development | 285.88K | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.46M | 20M | 36.07M | 58.56M | 168.66M |
| Operating Expenses | 9.02M | 422.02M | 66.55M | 65.64M | 168.66M |
| Depreciation & Amortization | 7.76M | 13.13M | 17.59M | 18.97M | 20.53M |
| EBITDA | 183.45M | (394.03M) | (14.58M) | 148.65M | 287.54M |
| EBITDA Margin | 55.3% | -179.7% | -5.9% | 31.0% | 32.9% |
| Operating Income | 170.26M | (406.6M) | (31.77M) | 130.62M | 275.63M |
| Operating Margin | 51.4% | -185.4% | -12.8% | 27.2% | 31.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 6.2M | 12.49M | 16.32M | 19.93M | 22.23M |
| Other Income / Expenses | (773.88K) | (13.05M) | (16.72M) | (20.87M) | (30.84M) |
| Income Before Tax | 169.49M | (419.65M) | (48.49M) | 109.75M | 244.78M |
| Pre-Tax Margin | 51.1% | -191.4% | -19.6% | 22.9% | 28.0% |
| Income Tax Expense | 965.73K | 13.09M | (5.07M) | 14.48M | 64.42M |
| Net Income | 132.59M | (424.78M) | (45.79M) | 52.18M | 70.79M |
| Net Margin | 40.0% | -193.7% | -18.5% | 10.9% | 8.1% |
| EPS (Basic) | 33.55 | (100.50) | (10.39) | 10.23 | 11.13 |
| EPS (Diluted) | 33.55 | (100.36) | (10.39) | 9.71 | 10.48 |
| Weighted Avg Shares | 4.02M | 4.23M | 4.41M | 5.1M | 6.36M |
| Weighted Avg Shares (Diluted) | 3.95M | 4.23M | 4.41M | 5.1M | 6.76M |
Nutex Health, Inc.
NASDAQ:NUTX
Intrinsic Alpha fair value
Locked
Current Price
$172.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.